Determination of pefloxacin concentration in mesenteric lymph nodes by high-performance chromatography.
作者信息
Munera M I, Cuesta F, Abadia A, Vasquez J, Restrepo M
机构信息
Corporación Investigaciones Biológicas, Medellín, Colombia.
出版信息
Antimicrob Agents Chemother. 1994 Mar;38(3):632-4. doi: 10.1128/AAC.38.3.632.
Abstract
Ten patients who had undergone laparotomies for different abdominal pathological conditions were studied to determine the levels of pefloxacin in mesenteric lymph nodes. Each patient was given 400 mg of oral pefloxacin every 12 h for the 3 days prior to surgery. Drug levels in tissue were determined by high-pressure liquid chromatography (reverse phase); the mean +/- standard deviation was 17.1 +/- 11.9 micrograms/g, with a range of 2.12 to 36.6 micrograms/g. This indicates an adequate pefloxacin concentration in lymph nodes and makes the drug a good option for the treatment of conditions in which lymph nodes act as an infection-promoting and/or relapse-favoring factor.
摘要
相似文献
1
Determination of pefloxacin concentration in mesenteric lymph nodes by high-performance chromatography.
Antimicrob Agents Chemother. 1994 Mar;38(3):632-4. doi: 10.1128/AAC.38.3.632.
2
Ocular kinetics of pefloxacin after intramuscular administration in albino and pigmented rabbits.培氟沙星在白化病兔和有色兔肌肉注射后的眼部动力学
Antimicrob Agents Chemother. 1991 Jun;35(6):1112-5. doi: 10.1128/AAC.35.6.1112.
3
4
Intravitreal penetration of oral pefloxacin in humans.口服培氟沙星在人体玻璃体内的渗透情况。
Int Ophthalmol. 1993 Aug;17(4):217-22. doi: 10.1007/BF01007743.
5
Kinetics and tolerability of intravitreal pefloxacin in rabbits.兔眼玻璃体内注射培氟沙星的药代动力学及耐受性
J Antimicrob Chemother. 1994 Feb;33(2):231-42. doi: 10.1093/jac/33.2.231.
6
Effect of an antacid containing magnesium and aluminum on absorption, metabolism, and mechanism of renal elimination of pefloxacin in humans.含镁铝抗酸剂对培氟沙星在人体中的吸收、代谢及肾脏排泄机制的影响。
Antimicrob Agents Chemother. 1994 May;38(5):1129-33. doi: 10.1128/AAC.38.5.1129.
7
[Acute epididymitis and antibiotherapy. Measurement of the epididymal diffusion of pefloxacin].[急性附睾炎与抗菌治疗。培氟沙星在附睾中的扩散测定]
J Urol (Paris). 1989;95(1):41-4.
8
[Diffusion of pefloxacin in the aqueous humor and crystalline lens after repeated oral administration in man].[人多次口服给药后培氟沙星在房水和晶状体中的扩散]
J Fr Ophtalmol. 1991;14(4):260-4.
9
Concentrations of pefloxacin in plasma and tissue after administration as surgical prophylaxis.作为手术预防用药给药后血浆和组织中培氟沙星的浓度。
Antimicrob Agents Chemother. 1998 Feb;42(2):425-7. doi: 10.1128/AAC.42.2.425.
10
Penetration of pefloxacin and its desmethyl metabolite into the uroepithelium after a 800-mg single oral dose in human patients.
Eur J Clin Pharmacol. 1996;49(5):401-5. doi: 10.1007/BF00203786.
本文引用的文献
1
Uptake of antibiotics by human alveolar macrophages.人肺泡巨噬细胞对抗生素的摄取。
Am Rev Respir Dis. 1984 Jun;129(6):933-7. doi: 10.1164/arrd.1984.129.6.933.
2
Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans.甲磺酸培氟沙星在小鼠、大鼠、犬、猴及人体内的吸收、分布、代谢转归及消除
Antimicrob Agents Chemother. 1984 Apr;25(4):463-72. doi: 10.1128/AAC.25.4.463.
3
[Postoperative infection in ORL oncologic surgery. The choice of preventive antibiotherapy. Experience of the ORL Department of Hôpital Claude Bernard].[耳鼻喉科肿瘤手术的术后感染。预防性抗生素治疗的选择。克劳德·伯纳德医院耳鼻喉科的经验]
Ann Otolaryngol Chir Cervicofac. 1985;102(3):187-93.
4
Penetration of pefloxacin in human heart valves.培氟沙星在人心脏瓣膜中的渗透情况。
J Antimicrob Chemother. 1986 Apr;17 Suppl B:89-92. doi: 10.1093/jac/17.suppl_b.89.
5
Improved high-performance liquid chromatographic determination of pefloxacin and its metabolite norfloxacin in human plasma and tissue.改进的高效液相色谱法测定人血浆和组织中的培氟沙星及其代谢产物诺氟沙星。
J Chromatogr. 1985 Apr 12;339(1):214-8. doi: 10.1016/s0378-4347(00)84647-2.
6
The diffusion of pefloxacin into bone and the treatment of osteomyelitis.
J Antimicrob Chemother. 1986 Apr;17 Suppl B:93-102. doi: 10.1093/jac/17.suppl_b.93.
7
Use of fluoroquinolones for intracellular pathogens.氟喹诺酮类药物用于细胞内病原体的治疗。
Rev Infect Dis. 1989 Jul-Aug;11 Suppl 5:S979-84. doi: 10.1093/clinids/11.supplement_5.s979.
8
Tissue penetration of the new quinolones in humans.新型喹诺酮类药物在人体中的组织穿透性。
Rev Infect Dis. 1989 Jul-Aug;11 Suppl 5:S1046-57. doi: 10.1093/clinids/11.supplement_5.s1046.
9
Fluoroquinolones in the treatment of typhoid fever and the carrier state.氟喹诺酮类药物治疗伤寒及带菌状态。
Eur J Clin Microbiol Infect Dis. 1991 Apr;10(4):334-41. doi: 10.1007/BF01967008.
10
Pharmacokinetics of quinolones: newer aspects.
Eur J Clin Microbiol Infect Dis. 1991 Apr;10(4):267-74. doi: 10.1007/BF01967000.
Zotero 插件